Claret Medical's Montage 2 Embolic Filter System Receives CE Mark Approval

February 27, 2013—Claret Medical, Inc. (Santa Rosa, CA) announced that the Montage 2 dual filter system received CE Mark approval. The company's second-generation filtration system features a catheter handle for increased simplicity and ease of use of the technology while providing complete neuroprotection and embolic capture during intravascular procedures, such as transcatheter aortic valve repair (TAVR).

The company noted that the Montage 2 device was featured during a live case at the JIM 2013: Joint Interventional Meeting in Rome in February. The case was performed by Prof. George Nickenig, MD, and Prof. Eberhard Grube, MD, both of University Hospital in Bonn, Germany.

Claret Medical stated that in clinical experience, the devices demonstrate significant debris capture during TAVR procedures, irrespective of the valve type used.

In the company's press release, John Webb, MD, of St. Paul's Hospital in Vancouver, Canada, commented on recent introduction of the device into his practice. “We have been impressed at the extent of embolic material we have been able to retrieve,” stated Dr. Webb.

“I have been delighted to see advancements in the Montage 2 delivery system, and our ability to protect TAVR patients from risk of embolic neurological deficit,” said Prof. Christoph Naber, MD, of Elisabeth-Krankenhaus at the Contilia Heart and Vascular Center in Essen, Germany.